Download PDF
Dtsch Med Wochenschr 2019; 144(12): 799-806
DOI: 10.1055/a-0747-0349
Dossier
© Georg Thieme Verlag KG Stuttgart · New York

HNO-ärztliche Therapie des Schwindels bei älteren Patienten

Dizziness, vertigo and unsteadiness with emphasis on problems in elderly patients
Martin Westhofen
Further Information

Publication History

Publication Date:
18 June 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Gait disturbance and risk for falls of the elderly are a major problem for neurotologic diagnosis and treatment. Diagnostic differentiation especially in the case of acute vestibular syndrome and in cases of chronic or recurrent paroxysmal vestibular deficits is mandatory for treatment indications. Criteria for medical, surgical conservative and surgical destructive therapy as well as for vestibular rehabilitation are outlined.

Schwindel stellt bei Älteren aufgrund von z. B. Gangstörungen und Sturzrisiken ein großes Problem dar. Diagnose und Behandlung sind eine Herausforderung. Vor der Therapie ist eine diagnostische Differenzierung v. a. bei akutem vestibulärem Syndrom und chronischen oder rezidivierenden paroxysmalen vestibulären Defiziten zwingend erforderlich. Im Folgenden wird auf Kriterien und Therapieformen aus Sicht des HNO-Arztes eingegangen.

Schlüsselwörter

Vestibulardiagnostik - plötzlicher Sturz - Gleichgewichtsstörung - Betahistin - vestibuläres System

Key words

function test - vestibular - accidental falls elderly - gait disorders sensorimotor - betahistin - vestibule - labyrinth
 

  • Literatur

  • 1 Zu Eulenburg P, Ruehl RM, Runge P. et al. Ageing-related changes in the cortical processing of otolith information in humans. Eur J Neurosci 2017; 46: 2817-2825
    CrossrefPubMedGoogle Scholar
  • 2 Walther LE, Westhofen M. Presbyvertigo-aging of otoconia and vestibular sensory cells. J Vestib Res 2007; 17: 89-92
    PubMedGoogle Scholar
  • 3 Damulin IV. Changes in walking in the elderly. Zh Nevrol Psikhiatr Im S S Korsakova 2018; 118: 100-104
    PubMedGoogle Scholar
  • 4 Tinetti ME, Williams CS, Gill TM. Health, functional, and psychological outcomes among older persons with chronic dizziness. J Am Geriatr Soc 2000; 48: 417-421
    CrossrefPubMedGoogle Scholar
  • 5 Fernandez L, Breinbauer HA, Delano PH. Vertigo and Dizziness in the Elderly. Front Neurol 2015; 6: 144
    CrossrefPubMedGoogle Scholar
  • 6 Murdin L, Schilder AG. Epidemiology of balance symptoms and disorders in the community: a systematic review. Otol Neurotol 2015; 36: 387-392
    CrossrefPubMedGoogle Scholar
  • 7 Neuhauser HK. Epidemiology of vertigo. Curr Opin Neurol 2007; 20: 40-46
    CrossrefPubMedGoogle Scholar
  • 8 von Brevern M, Radtke A, Lezius F. et al. Epidemiology of benign paroxysmal positional vertigo: a population based study. J Neurol Neurosurg Psychiatry 2007; 78: 710-715
    PubMedGoogle Scholar
  • 9 Albernaz PL, Cabral FS. Vertigo and dizziness in elderly patients with neurological disorders. Einstein 2011; 9: 466-469
    CrossrefPubMedGoogle Scholar
  • 10 Volz-Sidiropoulou E, Takahama J, Gauggel S. et al. The “dizziness handicap inventory”: initial psychometric evaluation of the German version. Laryngorhinootologie 2010; 89: 418-423
    Article in Thieme ConnectPubMedGoogle Scholar
  • 11 Eckhardt-Henn A, Breuer P, Thomalske C. et al. Anxiety disorders and other psychiatric subgroups in patients complaining of dizziness. J Anxiety Disord 2003; 17: 369-388
    CrossrefPubMedGoogle Scholar
  • 12 Adrion C, Fischer CS, Wagner J. et al. Efficacy and safety of betahistine treatment in patients with Meniere's disease: primary results of a long term, multicentre, double blind, randomised, placebo controlled, dose defining trial (BEMED trial). BMJ 2016; 352: h6816
    CrossrefPubMedGoogle Scholar
  • 13 Ernst A, Schlattmann P, Waldfahrer F. et al. Die Behandlung des M. Meniere mit Betahistin: Kritische Anmerkungen zur BEMED-Studie. Laryngorhinootologie 2017; 96: 519-521
    Article in Thieme ConnectPubMedGoogle Scholar
  • 14 Djelilovic-Vranic J, Alajbegovic A, Tiric-Campara M. et al. Betahistine or Cinnarizine for treatment of Meniere’s disease. Med Arch 2012; 66: 396-398
    CrossrefPubMedGoogle Scholar
  • 15 Shcherbakov DA, Raemgulov RA, Bukharova KP. et al. The effectiveness of the intra-tympanic administration of methylprednisolone and gentamycin for the treatment of Meniere’s disease. Vestn Otorinolaringol 2018; 83: 17-20
    PubMedGoogle Scholar
  • 16 Hong KS. Dual antiplatelet therapy after noncardioembolic ischemic stroke or transient ischemic attack: pros and cons. J Clin Neurol 2014; 10: 189-196
    PubMedGoogle Scholar
  • 17 Park JJ, Chen YS, Westhofen M. Meniere’s disease and middle ear pressure: vestibular function after transtympanic tube placement. Acta Otolaryngol 2009; 129: 1408-1413
    CrossrefPubMedGoogle Scholar
  • 18 Westhofen M. Indications for operative therapy of vestibular vertigo and the associated success rates. HNO 2013; 61: 752-761
    CrossrefPubMedGoogle Scholar
  • 19 Martins E Silva DC, Bastos VH, de Oliveira Sanchez M. et al. Effects of vestibular rehabilitation in the elderly: a systematic review. Aging Clin Exp Res 2016; 28: 599-606
    CrossrefPubMedGoogle Scholar